| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Stehlin Foundation for Cancer Research at St. Joseph Hospital, Houston, Texas 77003
We have determined that 9-nitro-20(S)-camptothecin (9NC) converts to 9-amino-20(S)-camptothecin (9AC) in humans, dogs, and mice. Following a single oral dose of 0.1 mg/kg of 9NC, the human plasma concentration reached a maximum concentration of 483 ng/ml at 3.4 h with an area under the curve (AUC) of 2.6 µg·h/ml and a half-life of 2.5 h. As conversion of 9NC to 9AC occurred, the maximum calculated concentration of 9AC was 14.0 ng/ml at 10.3 h with an AUC of 311 ng·h/ml and a half-life of 7.1 h. Following a single oral dose of 1.0 mg/kg of 9NC, the maximum concentration of 9NC in the human volunteer was 1247 ng/ml at 5.3 h with an AUC of 17194 ng·/ml and a half-life of 4.9 h. In this human, the Cmax of 9AC was 208 ng/ml at 17.2 h; the AUC was determined to be 9121 ng·h/ml, and the half-life was 13.1 h.
In a dog after a single oral dose of 1.0 mg/kg 9NC, the maximum concentration for 9NC was 19.1 ng/ml at 0.7 h with a half-life of 6.4 h and an AUC of 186 ng·h/ml. The maximum concentration of 9AC in this dog was 9.2 ng/ml at 2.9 h with an AUC of 310 ng·h/ml and a half-life of 21.1 h.
The maximum concentration of 9NC in the mouse after a single oral dose of 4.1 mg/kg of 9NC was 732 ng/ml at time 0.1 h with an AUC of 441 ng·h/ml and a half-life of 10.0 h. The maximum concentration of 9AC in the mouse was 26 ng/ml at 0.6 h. The AUC was 63 ng·h/ml, and the half-life was 1.2 h.
Incubation of mouse liver, spleen, kidney, brain, and muscle tissue with 9NC all indicated conversion to 9AC, yet no conversion was observable in cell-free plasma from human or mouse blood. Structural identification of 9AC was confirmed by mass spectrometry.
1 This work was supported by funds from The Stehlin Foundation for Cancer Research.
2 To whom requests for reprints should be addressed, at The Stehlin Foundation for Cancer Research, 1315 Calhoun Street, Suite 1818, Houston, TX 77003.
Received 2/25/94. Accepted 5/ 4/94.
This article has been cited by other articles:
![]() |
W. C. Zamboni, L. L. Jung, M. J. Egorin, D. R. Hamburger, E. Joseph, R. Jin, S. Strychor, R. K. Ramanathan, and J. L. Eiseman Relationship between Plasma Exposure of 9-Nitrocamptothecin and Its 9-Aminocamptothecin Metabolite and Antitumor Response in Mice Bearing Human Colon Carcinoma Xenografts Clin. Cancer Res., July 1, 2005; 11(13): 4867 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Li, X. Chen, D. Zhong, and Y. Li IDENTIFICATION OF THE METABOLITES OF 9-NITRO-20(S)-CAMPTOTHECIN IN RATS Drug Metab. Dispos., June 1, 2003; 31(6): 792 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Garcia-Carbonero and J. G. Supko Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins Clin. Cancer Res., March 1, 2002; 8(3): 641 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. SINGER, P. DE VRIES, R. BHATT, J. TULINSKY, P. KLEIN, C. LI, L. MILAS, R. A. LEWIS, and S. WALLACE Conjugation of Camptothecins to Poly-(l-Glutamic Acid) Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 136 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. KNIGHT, E. S. KLEINERMAN, J. C. WALDREP, B. C. GIOVANELLA, B. E. GILBERT, and N. V. KOSHKINA 9-Nitrocamptothecin Liposome Aerosol Treatment of Human Cancer Subcutaneous Xenografts and Pulmonary Cancer Metastases in Mice Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 151 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S-L. CHOW, L. GONG, M. D. WOLFE, and B. C. GIOVANELLA Modified Lactone/Carboxylate Salt Equilibria in Vivo by Liposomal Delivery of 9-Nitro-Camptothecin Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 164 - 174. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |